Xinrui Pharmaceuticals (06108) plans to discount about 8.16% and place up to 334.32 million shares to raise about HK$7.4 million in net placement shares

Zhitong Finance App News, Xinrui Pharmaceutical (06108) announced that on December 5, 2025, the Company entered into a placement agreement with the placement agent. The Company has agreed to place up to 334.32 million shares of placement shares to no less than six undertakers (themselves and their ultimate beneficial owners are independent third parties) at a price of HK$0.225 per share on a best-effort basis.

The highest number of placed shares is equivalent to approximately 20.00% of the Company's current issued share capital at the date of this announcement; and approximately 16.66% of the Company's issued share capital expanded by issuing placed shares. The placement price is HK$0.225 per share compared to the closing price of HK$0.245 per share on the last trading day of approximately 8.16%; and the average closing price of shares reported on the Stock Exchange for five consecutive trading days immediately before the last trading day is approximately HK$0.2516 per share discounted by approximately 10.57%.

Assuming that the highest number of shares placed is placed in accordance with the placement agreement, the total proceeds and net proceeds from the placement will be approximately HK$7.5 million and approximately HK$7.4 million respectively (after deducting placement fees and other expenses relating to the placement). It is anticipated that the full net proceeds from the placement will be used to acquire additional distribution rights in connection with the Group's core business.